BioCentury | Aug 15, 2019
Company News

Management tracks: New executives at Pfizer spinouts Cerevel and SpringWorks

...series B round led by Perceptive Advisors (see "SpringWorks Raises $125M" ). Oncolytic virus company Western Oncolytics...
...Moffitt Cancer Center and Research Institute. Jonathan Block, Associate Editor Aperiomics Inc. Cerevel Therapeutics LLC Isofol Medical AB M2Gen SpringWorks Therapeutics Inc. Western Oncolytics Ltd....
BioCentury | Aug 8, 2019
Tools & Techniques

Checkpoint inhibitors are bringing oncolytic viruses back into the spotlight

...other cancers for up to ¥3 billion ($28 million) upfront and in milestones Dec. 2016 Western Oncolytics Ltd....
...15-PGDH) genes to stimulate T cells and decrease immunosuppressive cells, respectively Preclinical NA Pfizer and Western Oncolytics...
BioCentury | Jun 29, 2015
Financial News

Western Oncolytics completes venture financing

Western Oncolytics Ltd. , Westlake, Ohio Business: Cancer Date completed: 2015-06-22 Type: Venture financing Raised: $2.5 million Investor: Tiberius II WIR Staff...
Items per page:
1 - 3 of 3
BioCentury | Aug 15, 2019
Company News

Management tracks: New executives at Pfizer spinouts Cerevel and SpringWorks

...series B round led by Perceptive Advisors (see "SpringWorks Raises $125M" ). Oncolytic virus company Western Oncolytics...
...Moffitt Cancer Center and Research Institute. Jonathan Block, Associate Editor Aperiomics Inc. Cerevel Therapeutics LLC Isofol Medical AB M2Gen SpringWorks Therapeutics Inc. Western Oncolytics Ltd....
BioCentury | Aug 8, 2019
Tools & Techniques

Checkpoint inhibitors are bringing oncolytic viruses back into the spotlight

...other cancers for up to ¥3 billion ($28 million) upfront and in milestones Dec. 2016 Western Oncolytics Ltd....
...15-PGDH) genes to stimulate T cells and decrease immunosuppressive cells, respectively Preclinical NA Pfizer and Western Oncolytics...
BioCentury | Jun 29, 2015
Financial News

Western Oncolytics completes venture financing

Western Oncolytics Ltd. , Westlake, Ohio Business: Cancer Date completed: 2015-06-22 Type: Venture financing Raised: $2.5 million Investor: Tiberius II WIR Staff...
Items per page:
1 - 3 of 3